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 1 
ABSTRACT 29 
Nutrition support involves the use of oral supplements, enteral tube feeding or parenteral 30 
nutrition. These interventions are considered when oral intake alone fails to meet nutritional 31 
requirements. Special diets and oral supplements are usually the first approach to managing 32 
malnutrition, however their role becomes limited when oral intake is restricted or if swallowing 33 
is unsafe. Enteral tube feeding or parenteral nutrition are alternative means of providing 34 
nutrition support for this select group of patients. 35 
 36 
Percutaneous Endoscopic Gastrostomy (PEG) feeding was introduced into clinical practice in 37 
1980. It describes a feeding tube placed directly into the stomach under endoscopic guidance. 38 
It is an established means of providing enteral nutrition to those who have functionally normal 39 
gastrointestinal tracts, but who cannot meet their nutritional requirements due to an inadequate 40 
oral intake. The intervention is usually reserved when nutritional intake is likely to be 41 
inadequate for more than 4-6 weeks. Although the benefits of PEGs have been shown for select 42 
group of patients, there currently exists concerns about the increasing frequency of this 43 
intervention, and also uncertainty about the long-term benefits for certain patients. The 2004 44 
UK National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report 45 
emphasized this concern, with almost a fifth of PEGs being undertaken for futile indications 46 
that negatively influenced morbidity and mortality. 47 
 48 
This review paper discusses the indications for, controversies surrounding, and complications 49 
of gastrostomy feeding and provides practical advice on optimising patient selection for this 50 
intervention.  51 
 52 
Keywords: Nutrition Support: Gastrostomy Feeding: Patient Selection 53 
  54 
 2 
Nutrition Support 55 
Nutrition support involves the provision of nutrition beyond that provided by normal food 56 
intake using oral supplementation, enteral tube feeding (ETF) and parenteral nutrition (PN).(1) 57 
The goals of nutrition support are to ensure attainment of an individuals nutritional 58 
requirements.  Oral nutrition using special diets and supplements is usually considered the first 59 
line therapy in managing malnutrition, however certain individuals may require enteral or 60 
parenteral nutrition when oral intake is reduced or when swallowing is unsafe.(2)  Of these 61 
modalities, enteral nutrition is usually preferred in the context of a normally functioning 62 
gastrointestinal tract as it is physiological, cheaper and may help maintain gut barrier 63 
function.(3; 4) 64 
 65 
Most patients requiring nutrition support therapy have treatment for less than one month.(5) 66 
When short-term enteral feeding is considered, nasogastric and orogastric tubes are most 67 
frequently used, reflecting their ease of insertion and removal (Figure 1). Tubes range in length 68 
and diameter and can be inserted either at the bedside, at endoscopy or using radiological 69 
guidance. When nutritional intake is likely to be inadequate for more than 4-6 weeks then 70 
enteral feeding using a gastrostomy is most frequently considered.(6)  71 
 72 
History of Gastrostomies  73 
A gastrostomy describes a feeding tube placed directly into the stomach via a small incision 74 
through the abdominal wall. It can provide long term enteral nutrition to patients who have 75 
functionally normal gastrointestinal tracts but who cannot meet their nutritional requirements 76 
due to an inadequate oral intake.(6) Infrequently, they may also be used for decompressing the 77 
stomach or proximal small bowel following outflow obstruction or volvulus.  78 
 79 
The concept of a gastrostomy was first proposed by Egeberg, a Norwegian army surgeon in 80 
1837, however it was only in 1876 when Verneuil used a silver wire to oppose visceral and 81 
parietal surfaces that success was achieved in inserting a surgical gastrostomy.(7) Post-82 
procedural peritonitis was the most frequent limitation to previous attempts at surgical 83 
insertion, with death ensuing in individuals who developed this complication. Stamm modified 84 
Verneuils surgical technique in 1894, prior to modifications being developed by Dragstedt, 85 
Janeway and Witze in the 20th century.(8)  86 
 87 
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In 1979, Michael Gauderer and Jeffrey Ponsky revolutionised gastrostomy practice by 88 
pioneering an endoscopic method of insertion in Clevleand, Ohio.(9) The two paediatricians 89 
performed the very first percutaneous endoscopic gastrostomy (PEG) in a 6-month old child, 90 
using a 16 French DePezzar (mushroom tipped) catheter, which they replicated again in a 91 
further 5 paediatric cases.(10) Ponsky then utilised this technique in a cohort of adult patients 92 
with dysphagic strokes, which heightened interest in this novel endoscopic technique.(10)  The 93 
pull technique that they pioneered is currently one of three endoscopic methods frequently 94 
used today in clinical practice. When compared to previously used surgical methods, 95 
endoscopic insertion was favourable, as it was minimally invasive and incurred lower 96 
morbidity and mortality.  97 
 98 
Two years later in 1981, Preshaw in Canada used fluoroscopic guidance to insert the first 99 
percutaneous radiological gastrostomy (PRG).(11) Like endoscopic methods, modifications of 100 
the original radiological technique have occurred since the original method was conceived. 101 
However, despite these advances endoscopic techniques remain the most popular methods of 102 
insertion internationally, with PRG insertion most frequently reserved for high-risk patients, 103 
oropharyngeal malignancy and when endoscopic passage is technically difficult.(12; 13) 104 
 105 
Indications for Gastrostomy 106 
Since the introduction of endoscopic and radiological insertion techniques for gastrostomy, 107 
there has been increasing demand for this intervention, for an increasing number of clinical 108 
indications. A broad list of indications for which patients are currently being referred for 109 
gastrostomy is given in Table 1. Despite being widely performed the evidence base to support 110 
gastrostomy feeding in certain patient groups is lacking. This is reflected in the National 111 
Confidential Enquiry into Patient Outcome and Death (NCEPOD) report, which reviewed 112 
mortality outcomes post-percutaneous endoscopic gastrostomy insertion between April 2002 113 
and March 2003.(14) This identified a 30-day mortality rate in a cohort of 16,648 patients of 114 
6%.(14) Subgroup analysis alarmingly showed that 43% died within one week of undergoing 115 
PEG insertion, of whom in 19% the intervention was felt to have been futile. Concerningly, 116 
the NCEPOD data identified a high prevalence of acute chest infections (40%) in those 117 
undergoing PEG placements, which could have influenced these mortality outcomes. 118 
Discussed below is the role of gastrostomy feeding in different patient subgroups, and the 119 
evidence that exists to inform clinical decision-making.  120 
 121 
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 122 
Gastrostomy feeding and Dementia 123 
Patients with dementia frequently develop feeding problems, leading to weight loss and 124 
nutritional deficiencies. Up to 85% of these problems develop prior to death suggesting that 125 
difficulties with feeding are an end-stage problem associated with advanced disease.(15) 126 
Whether or not to use gastrostomies to feed patients with dementia is an emotive and 127 
controversial issue. This controversy is further compounded by the fact that in the late stages 128 
of the illness, individuals lack capacity to express their wishes. The 2010 British Artificial 129 
Nutrition Survey (BANS) gives insights into the frequency of insertion for dementia, 130 
highlighting that registration of home enteral tube feeding (mainly by gastrostomy) for this 131 
indication declined from 7% in 2004 to 3% (48/1560).(16) This decline is likely to reflect 132 
concerns raised in the medical literature about inserting gastrostomies for this specific 133 
indication. 134 
 135 
There is currently a limited number of prospective studies examining outcomes in dementia, 136 
which could help inform clinical practice.(17; 18) In a retrospective cohort study of 361 patients, 137 
mortality was found to be significantly higher in dementia patients compared to any other 138 
patient group (54% 30-day mortality and 90% at 1 year).(19) Our group replicated this finding 139 
in a prospectively followed cohort (n=1023), however the number of insertions performed for 140 
the indication of dementia was low (n=5).(20) These concerns have been highlighted in a 141 
Cochrane systematic review, which showed no improvements in survival, quality of life, 142 
nutritional status, function, behaviour or in psychiatric symptoms in patients with advanced 143 
dementia receiving enteral tube feeding.(21)  144 
 145 
There now exists general agreement amongst clinicians that PEG feeding does not benefit 146 
people with advanced dementia. The evidence supporting this assertion has been disseminated 147 
through guidelines and enhanced education, and influenced the decline in gastrostomy 148 
insertions for this indication in the U.K. over recent years. Although this decline has been seen 149 
within the UK, the practice of inserting gastrostomies for this indication remains widespread 150 
in other countries.(22) The reasons for this geographical variation is uncertain but may reflect 151 
how factors such as cultural, religious, family and healthcare system expectations influence 152 
PEG decision making, which goes beyond clinic outcomes alone. In summary, gastrostomy 153 
feeding does not derive benefits to people with advanced dementia.  154 
 155 
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 156 
Gastrostomy Feeding in Stroke Patients 157 
Dysphagia is common in patients after a stroke ranging between 23-50%.(23) Neurological 158 
recovery does occur in some patients leading to improvements in swallowing function, 159 
however many remain at high risk of developing aspiration pneumonia and malnutrition. 160 
Enteral nutrition is widely advocated in these individuals, however controversy exists as to the 161 
optimal mode of delivery.  162 
 163 
Historically, two small randomised, studies evaluating PEG versus nasogastric feeding 164 
demonstrated improved mortality outcomes, hospital length of stay and nutritional indices in 165 
patients who had a PEG, suggesting derived benefit.(24; 25)  More recently, the FOOD (Feed or 166 
Ordinary Diet) trial has been published and questioned the potential merits of PEG feeding.(26) 167 
This multi-centre study consisted of three pragmatic randomised controlled trials: Trial 1 aimed 168 
to determine whether routine oral nutritional supplementation of a normal hospital diet 169 
improved outcomes after stroke); Trial 2 assessed whether early tube feeding improved the 170 
outcomes of dysphagic stroke patients; and Trial 3 examined whether tube feeding via a PEG 171 
resulted in better outcomes than nasogastric feeding. The results from this study showed no 172 
benefit of oral supplements; however, survival improved when tube feeding was commenced 173 
early but at the cost of poorer functional outcomes. In Trial 3 comparing PEG feeding versus 174 
nasogastric feeding, there was a significant difference between the 2 groups, with PEG fed 175 
patients likely to have a higher mortality and poorer outcomes. A possible explanation for this 176 
findings being the impact of dependency on long-term PEG feeding, with PEG patients still 177 
requiring feed during the follow-up period when compared to patients with nasogastric 178 
tubes.(26) Furthermore, survivors in the PEG group had a lower quality of life (based on EQ-179 
5D-5L, EuroQol Group), and were more likely to be living in institutions when compared to 180 
nasogastric fed patients.(26) In summary, enteral nutrition support is useful in patients with 181 
dysphagia following an acute stroke, however the optimal method of delivery (PEG vs. 182 
nasogastric feeding) remains uncertain.  183 
 184 
Gastrostomy Feeding in Oropharyngeal Malignancy 185 
Patients with oropharyngeal malignancy are at risk of malnutrition due to direct effects from 186 
the tumour (e.g. reduced appetite, host response, problems ingesting food due to tumour size) 187 
and also from the anticancer therapies themselves (e.g. radiation induced mucositis). PEGs and 188 
nasogastric tubes insertions are widely performed in this patient group as a prophylactic 189 
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measure (prior to radiotherapy and chemotherapy), but also when swallowing problems occur 190 
directly because of the malignancy itself. Despite the potential merits of enteral feeding in this 191 
patient group, there had been limited research evaluating gastrostomy feeding in comparison 192 
to other enteral feeding methods.(27) This led to a Cochrane review in 2010 concluding that 193 
there was insufficient evidence to determine the optimal method of enteral feeding in patients 194 
with head and neck cancer receiving radiotherapy and/or chemoradiotherapy.(28)  195 
 196 
More recently a prospective comparative cohort study from Australia compared no PEG (n=61) 197 
vs prophylactic PEG (n=69) in patients with head and neck cancer receiving chemotherapy. 198 
Over a two year period, prophylactic gastrostomy significantly improved nutritional outcomes 199 
and reduced unplanned hospital admissions.(29) A randomised controlled trial funded by the 200 
National Institute for Health Research (NIHR) Health Technology Assessment programme had 201 
planned to compare gastrostomy and nasogastric feeding in this cohort of patients and advance 202 
knowledge in this area, however poor recruitment limited trial progression.(30) In summary, 203 
further work is needed to establish when and which enteral feeding routes are most appropriate 204 
for this particular group of patients. 205 
 206 
Gastrostomy Feeding in Neurodegenerative Disorders 207 
Gastrostomies are increasingly being used in the treatment of patients with neurogenic 208 
dysphagia.(31) Whilst the exact aetiology of the neurogenic dysphagia is frequently unknown, 209 
it is commonly encountered in patients with motor neurone disease (MND), Huntingtons 210 
chorea, Multiple sclerosis and in patients with Parkinsons disease. When bulbar weakness 211 
develops leading to dyarthria and dysphagia, gastrostomies are frequently considered to aid 212 
nutrition, reduce choking episodes and to minimise the risk of aspiration pneumonia.  213 
 214 
PEG feeding is recommended for people with MND and dysphagia in both European and 215 
American guidelines.(32; 33) Despite patients potentially fulfilling criteria for insertion, it is 216 
recognised that patients and caregivers perceptions about PEG has an influence on both the 217 
timing and proportion that actually receive the intervention.(34) This variability has been subject 218 
to a meta-analysis and survey of clinical practice, which highlighted the dearth of high quality 219 
evidence regarding the optimal timing and method of gastrostomy insertion.(35)  This provided 220 
the rationale for the recent ProGas study, which was a large, multicentre, longitudinal cohort 221 
study.(36) This study compared the different methods of gastrostomy and explored the optimal 222 
timing for insertion.  Findings showed no differences between procedural methods for inserting 223 
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gastrostomies, and limited benefits in those who at the time of gastrostomy had had more than 224 
10% loss of their diagnosis weight. These findings have helped to inform both patients and 225 
relevant clinicians about the optimal timing of PEGs for people with MND. Further work is 226 
now needed to established the benefits derived to people with other neurodegenerative 227 
conditions. 228 
 229 
Gastrostomy Feeding in other Patient Sub-groups 230 
PEG insertion is undertaken for a number of other indications (highlighted in Table 1). The 231 
evidence supporting its role in some of these differing sub-groups is highly questionable. An 232 
example of this is in patients who suffer head injuries following road traffic accidents, falls, 233 
violence or sport who are often considered for gastrostomy whilst on Intensive Care Units. 234 
Currently, the latest Cochrane review of nutritional support in head injury patients (analysis of 235 
11 trials) suggests early feeding may improve survival and disability, however this benefit may 236 
be best derived from total parenteral nutrition rather than enteral nutrition methods.(37) When 237 
comparing nasogastric feeding with gastrostomy feeding in this patient group, gastrostomy 238 
feeding may reduce pneumonia rates but does not derive any mortality benefit.(38)  239 
 240 
Another group of patients seen in adult services with gastrostomies are patients with cerebral 241 
palsy. Gastrostomy insertion is increasingly being performed in children with this condition 242 
with the aim of improving weight, nutritional indices and quality of life.(39; 40; 41) These 243 
individuals are then moved into adult services as they reach adulthood. Unfortunately, like in 244 
many other areas of gastrostomy feeing there is a paucity of well-designed randomised 245 
controlled trials evaluating gastrostomy feeding in this patient group, leading to uncertainty 246 
regarding the merits of this intervention.(42) This uncertainty is reflected in other conditions 247 
(anorexia nervosa, achalasia, frailty, burns patients) and highlights the need for well-conducted 248 
studies, to help better inform clinical practice.  249 
 250 
 251 
Gastrostomy Feeding and Nutritional Outcomes 252 
Feeding via a Gastrostomy 253 
Enteral feeds can be delivered via gastrostomies using continuous, bolus or intermittent 254 
infusion methods.(43) These feeds are nutritionally complete (containing protein or amino acids, 255 
carbohydrate, fat, water, minerals and vitamins) and are available in fibre free and fibre 256 
enriched forms. Determining the type of feed used is influenced by an individuals, 257 
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preferences/lifestyle,  nutritional requirements, gastrointestinal absorption, motility and also 258 
by their co-morbidities, such as renal or liver disease.(44) Continuous infusion provides patients 259 
with feed over 24 hours. It is most frequently reserved for patients with high gastric residual 260 
volumes on intensive care units, and those having a history of aspiration, vomiting and/or 261 
reflux.(45) This regimen is associated with an increased risk of drug nutrient interactions and 262 
may also increase intragastric pH leading to bacterial overgrowth.(2) Bolus feeding describes 263 
the delivery of 200-400 mL of feed. periodically throughout the day. It permits medications to 264 
be given at times different to feeds, and also gives patients the freedom to mobilise and 265 
rehabilitate without having to be continually attached to a pump . Occasionally, this method of 266 
administration can lead to abdominal bloating, diarrhoea and rarely symptoms analogous to 267 
those seen in the dumping syndrome where rapid gastric emptying occurs. Intermittent 268 
infusions provide feeds over a longer duration than bolus feeding using an infusion pump. They 269 
are anecdotally most commonly used for ease and lifestyle reasons. 270 
 271 
Impact on nutritional outcomes.  272 
The nutritional benefits derived from gastrostomy feeding are not clearly established. The 273 
uncertainties that exist reflect the heterogeneity in populations previously assessed, the paucity 274 
of data examining long-term nutritional outcomes and confounders such as timing of 275 
gastrostomy feeding that may have influenced reported outcomes. In addition, the assessment 276 
of nutritional status is highly variable. In stroke patients, a frequently cited historical paper 277 
showed that gastrostomy feeding was better than nasogastric feeding at improving weight gain 278 
and anthropometric measurements at 6 weeks.(24) This landmark study has helped inform future 279 
clinical practice, however it is to be recognised that results were derived from only 30 patients 280 
from 2 UK centres. The more recent and significantly larger, multicentre FOOD trial has 281 
enhanced understanding about the timing and method of enteral feeding in stroke patients, 282 
however uncertainty still remains about how gastrostomies impact nutritional status in these 283 
individuals.(26)  284 
 285 
The ProGas study provides insights into how gastrostomy feeding influences nutritional 286 
outcomes in motor neurone disease.(36) In this study the authors report outcomes of 170 patients 287 
who had valid weight measurements 3 months post gastrostomy insertion. Findings showed 288 
that in 84 (49%) patients, weight loss was more than 1kg compared to baseline values. These 289 
findings suggest nutritional gains may be limited in this group of patients, however the timing 290 
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of gastrostomy insertion may by critical to achieving maximal gains. The uncertainties 291 
highlighted here emphasize the need for better studies looking at nutritional outcomes in 292 
gastrostomy patients. This would also help improve understanding of the efficacy of this 293 
intervention in reducing malnutrition. 294 
 295 
 296 
 297 
Improving patient selection for Gastrostomy insertion and aftercare 298 
There has been increasing interest in improving patient selection for gastrostomy insertion.(46; 299 
47; 48) One method used internationally to optimise referral practice is to employ institutional 300 
guidelines that use a standardised referral protocol. Use of a multidisciplinary team in 301 
assessment of patients and dissemination of evidence can allow both caregivers and healthcare 302 
professionals make an informed decision. This approach has been shown (in observational 303 
studies) to improve the selection of patients referred for gastrostomy.(49; 50; 51) These teams have 304 
varying composition but usually include a gastroenterologist, a specialist nurse, a dietitian and 305 
a speech and language therapist. Although these multidisciplinary teams have been advocated 306 
in differing reports from NCEPOD(14) and the British Society of Gastroenterology(52), it is 307 
recognised that many hospitals internationally are still unable to provide this service due to 308 
pressures within current healthcare systems.(53; 54) The may be a factor influencing the negative 309 
sequelae seen associated with PEG insertions.  310 
 311 
 312 
A cooling off period is another approach that is widely adopted and can help improve patient 313 
selection. This describes a gap of at least a week between assessment by the nutrition team and 314 
the scheduling of the PEG insertion.  This practice is based on previous published work by 315 
members of our clinical team, and data from the NCEPOD report, which highlighted that of 316 
those individuals that died within 30 days of PEG insertion, 43% died within the first 317 
week.(14;(49) This 7-day wait policy has two functions. Firstly, it serves to provide an 318 
opportunity to reflect on the implications of PEG tube insertion prior to undertaking the 319 
procedure (for all those involved in the decision-making process). Secondly, in some cases 320 
patients may succumb during this cooling off period, without the difficulty of having to 321 
undergo a PEG procedure.(55) 322 
 323 
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When considering whether insertion of a gastrostomy tube is merited, then consideration needs 324 
to be made to an individuals quality of life. This consideration must be done in the context of 325 
the underlying diagnosis and prognosis, considering moral and ethical issues, as well as 326 
respecting the patients wishes. Guidelines exist to aid clinicians in making decisions on 327 
gastrostomy feeding, however the decision to insert a feeding tube should always be made on 328 
an individual basis.(56; 57) Our recent quality of life work showed that quality of life was 329 
seemingly preserved in those undergoing gastrostomy insertion, however variation occurred 330 
dependent upon the indication.(58) The relevance of this work could again be in helping inform 331 
decision making for both clinicians and patients. 332 
 333 
Another factor that may be influencing outcomes following gastrostomy insertion is variations 334 
in the organisation of aftercare services. In a UK study looking at provision of services for 335 
gastrostomy, only 64% of units had a dedicated aftercare service.(53) The benefits of dedicated 336 
home enteral feed teams have been shown to reduce costs and morbidity associated with 337 
gastrostomy feeding.(59; 60) Given that most complications of gastrostomy feeding occur 338 
following hospital discharge, efforts need to be made to improve the delivery of aftercare 339 
services for these patients. 340 
 341 
Ethical and Legal Considerations of Gastrostomy feeding 342 
Gastrostomy feeding raises ethical and legal issues. Both the Royal College of Physicians and 343 
the General Medical Council in the UK have provided guidance on oral feeding and 344 
nutrition.(61; 62) Artificial Feeding is considered a medical treatment in legal terms and requires 345 
valid consent prior to commencement. For consent to be valid the person giving consent must 346 
have the capacity to do so voluntarily after being given sufficient information to guide informed 347 
choice.  When a patient has capacity their wish to consent to or refuse treatment should be 348 
upheld, even if that decision may lead to death. When a patient lacks capacity a best interests 349 
meeting should be held with the multidisciplinary team, those close to that patient or an 350 
independent mental capacity advocate. The multidisciplinary team caring for the patient is 351 
responsible for giving, withholding or withdrawing treatment, including artificial feeding and 352 
hydration and should consider any advance directives, the patients prognosis and the likely 353 
benefits of gastrostomy feeding when making decisions. A limited trial of feeding may 354 
sometimes be used but strict criteria regarding what constitutes success should be determined 355 
prior to starting gastrostomy feeding.(44) Conflicts sometimes arise between health care 356 
professionals or between the professionals and those close to the patient. In such circumstances 357 
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it may be necessary to seek legal advice or seek resolution through a local clinical ethics 358 
committee.(63) Anecdotally, such conflicts appear to be rising with increased patient and family 359 
demands for intervention, which may in turn be influenced by emotion or by cultural beliefs. 360 
 361 
The NICE dementia guidelines highlight the importance of quality of life in advanced 362 
dementia and support the role of palliative care in these individuals from diagnosis until 363 
death. Best practice in these patients could be to encourage eating and drinking by mouth for 364 
as long as tolerated, utilising good feeding techniques, altering food consistencies and to 365 
promote good mouth care. Assisting hand feeding in this way has recently been shown to be 366 
of benefit in elderly patients, with volunteer assistance improving oral intake and enjoyment 367 
of meals.(64) When disease progression is such that the patient no longer wants to eat or drink, 368 
then rather than inserting a gastrostomy tube, end of life care pathways might be considered. 369 
Views held by carers and medical staff may prevent progression to end of life care pathways. 370 
A questionnaire survey demonstrated that allied health care professionals were more likely 371 
than physicians to consider gastrostomy feeding when presented with patient scenarios 372 
relating to malnutrition.(65)  373 
 374 
Conclusion 375 
The provision of gastrostomy feeding remains a contentious issue. Decisions regarding 376 
insertions must take into account knowledge of the underlying disease process, prognosis and 377 
carefully consider the evidence regarding benefits and burdens. Patients and their caregivers 378 
need to be carefully counselled on these issues to help them make an informed choice. If the 379 
patient lacks capacity then those involved in the decision making should follow ethical and 380 
legal principles to determine what it is the patients best interests.  Future research in 381 
gastrostomy feeding should aim to better delineate those who will benefit most from this 382 
intervention and when is the optimal timing for PEG insertion.    383 
 384 
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Table 1  Indications where PEG feeding is considered 554 
Neurological Indications Obstruction 
Cerebrovascular Disease Oropharyngeal Cancer 
Motor Neurone Disease Oesophageal Cancer 
Multiple Sclerosis Oesophageal Stricture 
Muscular Dystrophy   
Parkinson's Disease Miscellaneous 
Cerebral Palsy Burns patients 
Dementia Fistulae 
  Cystic Fibrosis 
Reduced Conscious Level/Cognition Short Bowel Syndromes (e.g. Crohns disease) 
Head Injury Mental health (Anorexia/ Learning Difficulties) 
Intensive Care Patients   
 555 
556 
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Figure 1: Methods of Enteral feeding 557 
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